Abstract PO1-07-07: Radiomics features for distinguishing true recurrence versus new primary tumor following breast-conserving treatment
Feilin Qu(Fudan University Shanghai Cancer Center), Jinhui Li(Fudan University Shanghai Cancer Center), Guan-Hua Su(Fudan University Shanghai Cancer Center), Chao You(Fudan University Shanghai Cancer Center)
Cited by 0
Related Papers
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
|Signal Transduction and Targeted Therapy|2021|171
Radiomics in breast cancer: Current advances and future directions
|Cell Reports Medicine|2024|143
Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
|Science Advances|2023|114
Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
|Cell Reports Medicine|2022|92